Literature DB >> 32570988

Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target.

Ricardo Gargini1, Berta Segura-Collar1, Pilar Sánchez-Gómez1.   

Abstract

pan class="Disease">Brain tumors encompass a diverse group of pan class="Disease">neoplasias arising from different cell lineages. Tumors of glial origin have been the subject of intense research because of their rapid and fatal progression. From a clinical point of view, complete surgical resection of gliomas is highly difficult. Moreover, the remaining tumor cells are resistant to traditional therapies such as radio- or chemotherapy and tumors always recur. Here we have revised the new genetic and epigenetic classification of gliomas and the description of the different transcriptional subtypes. In order to understand the progression of the different gliomas we have focused on the interaction of the plastic tumor cells with their vasculature-rich microenvironment and with their distinct immune system. We believe that a comprehensive characterization of the glioma microenvironment will shed some light into why these tumors behave differently from other cancers. Furthermore, a novel classification of gliomas that could integrate the genetic background and the cellular ecosystems could have profound implications in the efficiency of current therapies as well as in the development of new treatments.

Entities:  

Keywords:  EGFR; IDH mutations; blood-brain-barrier; endothelium; genetic and epigenetic alterations; glioblastoma; glioma subtypes; immune infiltrate; lower grade glioma; pericytes; tumor microenvironment; tumor-associated-macrophages

Year:  2020        PMID: 32570988     DOI: 10.3390/cancers12061622

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

1.  Glioblastoma microenvironment contains multiple hormonal and non-hormonal growth-stimulating factors.

Authors:  Daniel Dahlberg; Jutta Rummel; Sonia Distante; Gustavo Antonio De Souza; Maria Ekman Stensland; Espen Mariussen; Helge Rootwelt; Øyvind Voie; Bjørnar Hassel
Journal:  Fluids Barriers CNS       Date:  2022-06-04

2.  IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas.

Authors:  Ricardo Gargini; Berta Segura-Collar; María Garranzo-Asensio; Rafael Hortigüela; Patricia Iglesias-Hernández; Daniel Lobato-Alonso; Miguel Moreno-Raja; Santiago Esteban-Martin; Juan M Sepúlveda-Sánchez; Laura Nevola; Pilar Sánchez-Gómez
Journal:  Neurotherapeutics       Date:  2022-01-31       Impact factor: 6.088

Review 3.  Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment.

Authors:  Yuxiang Fan; Yubo Wang; Jian Zhang; Xuechao Dong; Pu Gao; Kai Liu; Chengyuan Ma; Gang Zhao
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

4.  CD44 expressed by myeloid cells promotes glioma invasion.

Authors:  Ekaterina L Ivanova; Barbara Costa; Tanja Eisemann; Sabrina Lohr; Pavle Boskovic; Viktoria Eichwald; Jasmin Meckler; Manfred Jugold; Veronique Orian-Rousseau; Heike Peterziel; Peter Angel
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

5.  Prognostic Value of MEG3 and Its Correlation With Immune Infiltrates in Gliomas.

Authors:  Xiaoping Xu; Zhenglan Zhong; Yongxiang Shao; Yong Yi
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.